ARTICLE | Clinical News
Bind Biosciences preclinical data
August 30, 2010 7:00 AM UTC
In a mouse model of solid tumors, BIND-014 delivered up to 20 times more docetaxel to the tumor site than an equivalent dose of Taxotere docetaxel from sanofi-aventis Group (Euronext:SAN; NYSE:SNY, ...